Zoetis Inc.ZTS
NYSE•Healthcare•Drug Manufacturers - Specialty & Generic
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $9.51B, growing 2.4% year-over-year. TTM net income stood at $2.64B (5.0% growth). Quarterly EBITDA was $919.00M and operating income was $800.00M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze ZTS growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters